Unrelated adult stem cell donor medical suitability: recommendations from the World Marrow Donor Association Clinical Working Group Committee.

↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Sökning: WFRF:(Bengtsson M.) > Unrelated adult ste...

LIBRIS Formathandbok (Information om MARC21)

Fältnamn	Indikatorer	Metadata
000		02908naa a2200409 4500
001		oai:DiVA.org:uu-487859
003		SwePub
008		221103s2014 \| \|\|\|\|\|\|\|\|\|\|\|000 \|\|eng\|
024	7	a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4878592 URI
024	7	a https://doi.org/10.1038/bmt.2014.672 DOI
040		a (SwePub)uu
041		a engb eng
042		9 SwePub
072	7	a ref2 swepub-contenttype
072	7	a art2 swepub-publicationtype
100	1	a Lown, R N4 aut
245	1 0	a Unrelated adult stem cell donor medical suitability :b recommendations from the World Marrow Donor Association Clinical Working Group Committee.
264		c 2014-04-07
264	1	b Springer Science and Business Media LLC,c 2014
338		a print2 rdacarrier
520		a The World Marrow Donor Association (WMDA) fosters collaboration between international registries to facilitate the exchange of hematopoietic stem cell products for unrelated stem cell donor transplantation. As indications for hematopoietic SCT grow, the movement of products across the world will increase. Although competent authorities may regulate products within their country, there is a need to protect the best interests of donors and recipients by identifying universal donor medical suitability criteria. Within this report the WMDA provides a background to unrelated adult donor and recipient safety, recommends a common framework for assessing the health of unrelated adult donors at each stage of the donation pathway and presents a novel mechanism for sharing international consensus criteria for individual medical and lifestyle conditions. Wherever possible, these criteria are evidence-based. By establishing a donor medical suitability working group, the WMDA has developed a process through which donor centers and registries may request a consensus opinion on conditions not already listed, as well as challenge existing criteria. Guidance from the WMDA is intended to complement, not supersede, guidance from national competent authorities and international regulatory bodies.
700	1	a Philippe, J4 aut
700	1	a Navarro, W4 aut
700	1	a van Walraven, S M4 aut
700	1	a Philips-Johnson, L4 aut
700	1	a Fechter, M4 aut
700	1	a Pawson, R4 aut
700	1	a Bengtsson, Mu Uppsala universitet,Institutionen för immunologi, genetik och patologi4 aut
700	1	a Beksac, M4 aut
700	1	a Field, S4 aut
700	1	a Yang, H4 aut
700	1	a Shaw, B E4 aut
710	2	a Uppsala universitetb Institutionen för immunologi, genetik och patologi4 org
773	0	t Bone Marrow Transplantationd : Springer Science and Business Media LLCg 49:7, s. 880-6q 49:7<880-6x 0268-3369x 1476-5365
856	4	u https://www.nature.com/articles/bmt201467.pdf
856	4 8	u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-487859
856	4 8	u https://doi.org/10.1038/bmt.2014.67

Hitta via bibliotek

Bone Marrow Transplantation (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Hitta mer i SwePub

Av författaren/redakt...: Lown, R N; Philippe, J; Navarro, W; van Walraven, S ...; Philips-Johnson, ...; Fechter, M; visa fler...; Pawson, R; Bengtsson, M; Beksac, M; Field, S; Yang, H; Shaw, B E; visa färre...

Artiklar i publikationen: Bone Marrow Tran ...

Av lärosätet: Uppsala universitet

Sök utanför SwePub

Sök vidare i:: Google; Google Book Search; Google Scholar

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

LIBRIS.kb.se